ArticleCancer medicine2023

Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) study.

Hagit Peretz Soroka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.